Summit Therapeutics (SMMT) Q2 2025 Earnings

1MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.09
-0.08
-0.06
-0.05

Details

Expected EPS
-0.093019
Actual EPS
-0.09
Surprise EPS
0
Surprise Percent
+3.25%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.09 per share for Q2 2025.

0 Comments

Share your thoughts